Beta-lactams linked to hemolytic uremic syndrome in children, adults with E. coli

10/17/2013 | Family Practice News

In a study involving 1,308 people with Shiga toxin–producing Escherichia coli 0157 infection, researchers found that treatment with beta-lactam antibiotics and sulfonamides was tied to at least partial postdiarrheal hemolytic uremic syndrome in children and adults. Treatments with any antibiotics and metronidazole were associated with HUS in young patients between ages 5 and 14. The findings were presented at the IDWeek meeting.

View Full Article in:

Family Practice News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN